Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milind Javle

Showing results (31-40 of 226) with videos related to

Pageof 23
Sort By:
JOP : Journal of the Pancreas|November 13, 2004
Anaplastic pancreatic carcinoma. A case report and review of literature Manpreet K Chadha, Charles LeVea, Milind Javle, et al.
Cancer|July 29, 2010
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancerMotofumi Tanaka, Milind Javle, Xiaoqun Dong, et al.
American Journal of Clinical Oncology|August 3, 2005
Cisplatin and gemcitabine for small cell carcinoma of the gall bladderSandeep Bahadur, Aasma Shaukat, John Gibbs, et al.
The Journal of Molecular Diagnostics : JMD|March 8, 2016
Somatic Mutations of PI3K in Early and Advanced Gallbladder Cancer: Additional Options for an Orphan CancerIvan Roa, Hernan Garcia, Anakaren Game, et al.
Transplantation|December 14, 2021
Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus ConferenceMagdalena Salcedo, Carmen Vinaixa, Milind Javle, et al.
Cancer Journal (Sudbury, Mass.)|October 5, 2023
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?Eugene J Koay, Milind Javle, Madeline Belknap, et al.
Gastrointestinal Cancer Research : GCR|May 7, 2014
Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder CancerIván Roa, Gonzalo de Toro, Kurt Schalper, et al.
Plos One|January 28, 2014
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancerMilind Javle, Yanan Li, Dongfeng Tan, et al.
Journal of Surgical Oncology|February 27, 2007
Cystic pancreatic tumors (CPT): predictors of malignant behaviorMilind Javle, Pankaj Shah, Jihnhee Yu, et al.
Hepatic Medicine : Evidence and Research|December 25, 2013
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinomaJen-Jung Pan, Milind Javle, Mie Mie Thinn, et al.
Pageof 23

Showing results (31-40 of 226) with videos related to

Sort By:
Pageof 23
JOP : Journal of the Pancreas|November 13, 2004
Anaplastic pancreatic carcinoma. A case report and review of literature Manpreet K Chadha, Charles LeVea, Milind Javle, et al.
Cancer|July 29, 2010
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancerMotofumi Tanaka, Milind Javle, Xiaoqun Dong, et al.
American Journal of Clinical Oncology|August 3, 2005
Cisplatin and gemcitabine for small cell carcinoma of the gall bladderSandeep Bahadur, Aasma Shaukat, John Gibbs, et al.
The Journal of Molecular Diagnostics : JMD|March 8, 2016
Somatic Mutations of PI3K in Early and Advanced Gallbladder Cancer: Additional Options for an Orphan CancerIvan Roa, Hernan Garcia, Anakaren Game, et al.
Transplantation|December 14, 2021
Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus ConferenceMagdalena Salcedo, Carmen Vinaixa, Milind Javle, et al.
Cancer Journal (Sudbury, Mass.)|October 5, 2023
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?Eugene J Koay, Milind Javle, Madeline Belknap, et al.
Gastrointestinal Cancer Research : GCR|May 7, 2014
Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder CancerIván Roa, Gonzalo de Toro, Kurt Schalper, et al.
Plos One|January 28, 2014
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancerMilind Javle, Yanan Li, Dongfeng Tan, et al.
Journal of Surgical Oncology|February 27, 2007
Cystic pancreatic tumors (CPT): predictors of malignant behaviorMilind Javle, Pankaj Shah, Jihnhee Yu, et al.
Hepatic Medicine : Evidence and Research|December 25, 2013
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinomaJen-Jung Pan, Milind Javle, Mie Mie Thinn, et al.
Pageof 23